melatonin and Sarcoidosis, Pulmonary studies

Sarcoidosis, Pulmonary: Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)

Research Excerpts

Excerpt	Relevance	Reference
"Melatonin was given for 2 yr (20 mg/day in the first year, 10 mg/day in the second year) to 18 CS patients."	6.72	Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis. ( Becucci, A; Benvenuti, C; Carossino, AM; Conforti, ML; Fiori, G; Generini, S; Gramigna, L; Livi, R; Matucci-Cerinic, M; Perfetto, F; Pignone, AM; Rosso, AD; Tempestini, A, 2006)
"Melatonin was given for 2 yr (20 mg/day in the first year, 10 mg/day in the second year) to 18 CS patients."	2.72	Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis. ( Becucci, A; Benvenuti, C; Carossino, AM; Conforti, ML; Fiori, G; Generini, S; Gramigna, L; Livi, R; Matucci-Cerinic, M; Perfetto, F; Pignone, AM; Rosso, AD; Tempestini, A, 2006)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

melatonin and Sarcoidosis, Pulmonary

Research Excerpts

Research

Studies (1)

Authors

Trials

Authors	Studies
Pignone, AM	1
Rosso, AD	1
Fiori, G	1
Matucci-Cerinic, M	1
Becucci, A	1
Tempestini, A	1
Livi, R	1
Generini, S	1
Gramigna, L	1
Benvenuti, C	1
Carossino, AM	1
Conforti, ML	1
Perfetto, F	1